No: No interaction but be mindful of possible decrease in bp.
Answered 7/31/2016
5.5k views
Severity = Moderate: Monitor blood pressure response to phosphodiesterase 5 (pde5) inhibitors in patients receiving concurrent antihypertensive therapy. Pde5 inhibitors can cause additional mild-moderate blood pressure reductions (and related adverse effects, such as dizziness, lightheadedness, and/or fainting), and the magnitude of this effect may vary somewhat depending on the particular antihypertensive therapy.
Answered 10/3/2016
5.5k views
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question